Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

References for PMC Articles for PubMed (Select 10225954)

1.

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3540-5.

2.

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM.

Nature. 1999 Jan 28;397(6717):315-23.

PMID:
9950424
3.

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K, Morinaga T, Higashio K.

Biochem Biophys Res Commun. 1998 Dec 18;253(2):395-400.

PMID:
9878548
4.

The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor.

Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y.

J Biol Chem. 1998 Oct 23;273(43):28355-9.

5.

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

Fuller K, Wong B, Fox S, Choi Y, Chambers TJ.

J Exp Med. 1998 Sep 7;188(5):997-1001.

7.

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.

Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS.

Genes Dev. 1998 May 1;12(9):1260-8.

8.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ.

Cell. 1998 Apr 17;93(2):165-76.

9.

c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase.

Chellaiah M, Fitzgerald C, Alvarez U, Hruska K.

J Biol Chem. 1998 May 8;273(19):11908-16.

10.

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602.

11.

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K.

Endocrinology. 1998 Mar;139(3):1329-37.

PMID:
9492069
12.

Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading.

Lakkakorpi PT, Wesolowski G, Zimolo Z, Rodan GA, Rodan SB.

Exp Cell Res. 1997 Dec 15;237(2):296-306.

PMID:
9434625
13.

Integrin function in osteoclasts.

Rodan SB, Rodan GA.

J Endocrinol. 1997 Sep;154 Suppl:S47-56. Review.

14.

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.

Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L.

Nature. 1997 Nov 13;390(6656):175-9.

PMID:
9367155
15.

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells.

Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, Kalachikov S, Cayani E, Bartlett FS 3rd, Frankel WN, Lee SY, Choi Y.

J Biol Chem. 1997 Oct 3;272(40):25190-4.

16.

Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts.

Nakamura I, Sasaki T, Tanaka S, Takahashi N, Jimi E, Kurokawa T, Kita Y, Ihara S, Suda T, Fukui Y.

J Cell Physiol. 1997 Aug;172(2):230-9.

PMID:
9258344
17.

Regulation of osteoclast function.

Suda T, Nakamura I, Jimi E, Takahashi N.

J Bone Miner Res. 1997 Jun;12(6):869-79. Review. No abstract available.

PMID:
9169344
18.

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis.

Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T, Higashio K.

Biochem Biophys Res Commun. 1997 May 8;234(1):137-42.

PMID:
9168977
19.

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, L├╝thy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ.

Cell. 1997 Apr 18;89(2):309-19.

20.

Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.

Nakamura I, Takahashi N, Sasaki T, Jimi E, Kurokawa T, Suda T.

J Bone Miner Res. 1996 Dec;11(12):1873-9.

PMID:
8970888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk